„ chorobu- modifikující “ antirevmatikum (DMARD = disease- modifying antirheumatic drug), • aktivní psoriatrickou artritidou.
Leflunomide is indicated for the treatment of adult patients with: • active rheumatoid arthritis as a "disease-modifying antirheumatic drug" (DMARD), • active psoriatic arthritis,.